Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-16 4:39 pm Purchase | 13G | KINNATE BIOPHARMA INC KNTE | RA CAPITAL MANAGEMENT L.P. | 3,593,052 8.3% | 3,593,052 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | INOZYME PHARMA INC INZY | RA CAPITAL MANAGEMENT L.P. | 2,003,653 8.6% | 2,003,653 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | LARIMAR THERAPEUTICS INC LRMR | RA CAPITAL MANAGEMENT L.P. | 1,515,151 9.9% | 1,515,151 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | AKOUOS INC AKUS | RA CAPITAL MANAGEMENT L.P. | 2,281,249 6.6% | 2,281,249 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | LYRA THERAPEUTICS INC LYRA | RA CAPITAL MANAGEMENT L.P. | 815,849 6.3% | 815,849 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | MACROGENICS INC MGNX | RA CAPITAL MANAGEMENT L.P. | 4,375,217 7.8% | 4,375,217 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | OLEMA PHARMACEUTICALS INC OLMA | RA CAPITAL MANAGEMENT L.P. | 2,150,404 5.4% | 2,150,404 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | PANDION THERAPEUTICS INC PAND | RA CAPITAL MANAGEMENT L.P. | 1,770,023 6% | 1,770,023 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | RA CAPITAL MANAGEMENT L.P. | 2,327,714 7.8% | 2,327,714 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | Trillium Therapeutics Inc. TRIL | RA CAPITAL MANAGEMENT L.P. | 5,290,481 5.3% | 5,290,481 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | ARDELYX INC ARDX | RA CAPITAL MANAGEMENT L.P. | 6,163,086 6.8% | 635,998 (+11.51%) | View |
| 2021-02-16 4:39 pm Purchase | 13G | CHEMOCENTRYX INC CCXI | RA CAPITAL MANAGEMENT L.P. | 4,776,548 6.9% | 1,577,159 (+49.30%) | View |
| 2021-02-16 4:39 pm Purchase | 13G | ARYA SCIENCES ACQUISITION CORP ARYA | RA CAPITAL MANAGEMENT L.P. | 1,000,000 6.7% | 1,000,000 (New Position) | View |
| 2021-02-16 4:39 pm Sale | 13G | CRINETICS PHARMACEUTICALS INC CRNX | RA CAPITAL MANAGEMENT L.P. | 564,102 1.7% | -1,311,107 (-69.92%) | View |
| 2021-02-16 4:39 pm Sale | 13G | VAXCYTE INC PCVX | RA CAPITAL MANAGEMENT L.P. | 3,710,699 7.3% | -1,778,482 (-32.40%) | View |
| 2021-02-16 4:39 pm Purchase | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | RA CAPITAL MANAGEMENT L.P. | 3,825,008 12.3% | 178,200 (+4.89%) | View |
| 2021-02-16 4:39 pm Purchase | 13G | ZOGENIX INC ZGNX | RA CAPITAL MANAGEMENT L.P. | 5,345,631 9.6% | 3,084,880 (+136.45%) | View |
| 2021-02-16 4:39 pm Purchase | 13G | SCPHARMACEUTICALS INC SCPH | RA CAPITAL MANAGEMENT L.P. | 3,518,998 12.9% | 271,993 (+8.38%) | View |
| 2021-02-16 4:39 pm Purchase | 13G | BCLS ACQUISITION CORP BLSA | RA CAPITAL MANAGEMENT L.P. | 1,250,000 8.4% | 1,250,000 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | 5:01 ACQUISITION CORP FVAM | RA CAPITAL MANAGEMENT L.P. | 750,000 8.7% | 750,000 (New Position) | View |